Thomas Lenzmeier, MD
Family Medicine · Glendale, AZNPI 1932120441
Payments from drug & device makers
Across 1,320 payments — averaging $3389.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$1.6M
- Modernatx, Inc.$964K
- Merck$735K
- Bavarian Nordic A/s$280K
- AstraZeneca$236K
- Novo Nordisk AS$234K
- plus $403K from 21 others
Across 11 payments — averaging $93.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 123 | $1,621,306 |
| Modernatx, Inc. | 434 | $963,906 |
| Merck | 19 | $735,213 |
| Bavarian Nordic A/s | 67 | $280,243 |
| AstraZeneca | 34 | $235,829 |
| Novo Nordisk AS | 359 | $233,567 |
| AbbVie | 56 | $128,546 |
| Novartis | 7 | $82,978 |
| Genentech, Inc. | 42 | $74,774 |
| Regeneron | 24 | $67,919 |
| Alnylam Pharmaceuticals Inc. | 79 | $32,125 |
| Astrazeneca UK Limited | 2 | $9,729 |
| Visby Medical, Inc. | 1 | $5,500 |
| Novo Nordisk | 35 | $1,039 |
| Lilly USA, LLC | 12 | $269 |
| Edwards Lifesciences | 3 | $132 |
| GSK | 6 | $106 |
| Sanofi Pasteur Inc. | 3 | $66 |
| Boston Scientific | 3 | $56 |
| Abbott | 2 | $37 |
| Amgen | 2 | $34 |
| Seqirus USA Inc | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Exact Sciences | 1 | $14 |
| Hologic Sales And Service, LLC | 1 | $14 |
| Phadia US Inc. | 1 | $12 |
How this compares
$4,473,480 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Glendale
- Rachel LanglandGlendale$83K
- Danielle ArmasScottsdale$73M
- Terry O'ReillyMesa$35.8M
- Shawn SearleChandler$27M
- Corey AndersonMesa$21.5M
- Dena PetersenTucson$14.7M
- Gerald ShockeyMesa$12.3M
- Brock MerrittPhoenix$8.4M
- John McGettiganTucson$8.3M
- Neil ShethChandler$6.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.